Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

PaperCitations, authors & open-access status

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 645 citations, 2018 year and closed oa status.

645
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Alan G. Zimmermann
Author
Brian Rayner
Author
Mark Lakshmanan
Author
Robert S. Busch
Author
Fady T. Botros
Author
The Lancet Diabetes & Endocrinology
Journal
470M+ articles · free account